SCHEMBL22677156

SCHEMBL22677156

CCc1ccc(Oc2nccc(C)n2)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 2/20 0.43
▸ FEN1 P39748 2/20 0.43
▸ TRPA1 O75762 4/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ FGFR2 P21802 1/20 0.37
▸ FGFR4 P22455 1/20 0.37
▸ FGFR3 P22607 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ AXL P30530 2/20 0.36
▸ RXRA P19793 2/20 0.36
▸ GRIN1 Q05586 2/20 0.36
▸ GRIN2B Q13224 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22676393 0.82 ALOX5AP (0.46) ALOX5APFEN1TRPA1CYP3A4CYP2D6
SCHEMBL24773521 0.80 ALOX5AP (0.45) ALOX5APFEN1TRPA1CYP3A4CYP2D6
SCHEMBL30306048 0.80 ALOX5AP (0.45) ALOX5APFEN1TRPA1CYP3A4CYP2D6
SCHEMBL25714089 0.80 ALOX5AP (0.45) ALOX5APFEN1TRPA1CYP3A4CYP2D6
SCHEMBL26585989 0.80 ALOX5AP (0.50) ALOX5APFEN1TRPA1CYP3A4CYP2D6
SCHEMBL31129024 0.74 RXRA (0.45) ALOX5APFEN1TRPA1CYP3A4CYP2D6
SCHEMBL22659251 0.72 ALOX5AP (0.39) ALOX5APFEN1TRPA1CYP3A4CYP2D6
SCHEMBL25129367 0.72 ALOX5AP (0.41) ALOX5APFEN1TRPA1CYP3A4CYP2D6
SCHEMBL24773007 0.71 ALOX5AP (0.53) ALOX5APFEN1CYP3A4CYP2D6FGFR1
SCHEMBL30717991 0.71 ALOX5AP (0.50) ALOX5APFEN1TRPA1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306529-A2 FGFR INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2024-01-17 — — EP disclosed
WO-2020231990-A1 FGFR INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2020-11-19 — — WO disclosed
Send feedback